These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22147771)
21. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population. El Ghannam D; Fawzy IM; Azmy E; Hakim H; Eid I Immunol Invest; 2015; 44(7):616-26. PubMed ID: 26436850 [TBL] [Abstract][Full Text] [Related]
22. STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia. Chen Z; Guo Z; Ma J; Liu F; Gao C; Liu S; Wang A; Wu R Autoimmunity; 2015; 48(5):305-12. PubMed ID: 25707685 [TBL] [Abstract][Full Text] [Related]
23. Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients. Eyada TK; Amin DG; Samih I; Khedr SM Hematology; 2018 Mar; 23(2):111-116. PubMed ID: 28823219 [TBL] [Abstract][Full Text] [Related]
24. No impact of PTPN22, PTPRJ and ACP1 genes polymorphisms on the risk of immune thrombocytopenia in French adult patients. Lioger B; Rollin J; Vayne C; Perret-Gallix K; Pouplard C; Godeau B; Michel M; Gruel Y Thromb Res; 2016 Aug; 144():76-8. PubMed ID: 27309885 [No Abstract] [Full Text] [Related]
25. FAS mutations are an uncommon cause of immune thrombocytopenia in children and adults without additional features of immunodeficiency. Vandrovcova J; Salzer U; Grimbacher B; Wanders J; Rao K; Thrasher A; Burns S; Gilmore K; Bussel J; Cooper N Br J Haematol; 2019 Sep; 186(6):e163-e165. PubMed ID: 31172514 [No Abstract] [Full Text] [Related]
26. FC gamma receptor polymorphisms in patients with immune thrombocytopenia. Pavkovic M; Petlichkovski A; Karanfilski O; Cevreska L; Stojanovic A Hematology; 2018 Apr; 23(3):163-168. PubMed ID: 28942727 [TBL] [Abstract][Full Text] [Related]
28. Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia. Lyu M; Li Y; Hao Y; Sun T; Liu W; Lyu C; Fu R; Li H; Xue F; Liu X; Zhang L; Yang R Platelets; 2016 Jun; 27(4):338-43. PubMed ID: 26587874 [TBL] [Abstract][Full Text] [Related]
29. Macrothrombocytopenia associated with a rare GFI1B missense variant confounding the presentation of immune thrombocytopenia. Cheng AN; Bao EL; Fiorini C; Sankaran VG Pediatr Blood Cancer; 2019 Sep; 66(9):e27874. PubMed ID: 31207059 [TBL] [Abstract][Full Text] [Related]
30. FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome. Papagianni A; Economou M; Tragiannidis A; Karatza E; Samarah F; Gombakis N; Athanassiadou-Piperopoulou F; Vavatsi-Christaki N; Athanassiou-Metaxa M Blood Coagul Fibrinolysis; 2013 Jan; 24(1):35-9. PubMed ID: 23249566 [TBL] [Abstract][Full Text] [Related]
32. A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia. El-Beblawy NM; Elbarbary NS; Kamal TM; Mahmoud PM Clin Appl Thromb Hemost; 2016 Jul; 22(5):429-40. PubMed ID: 25792670 [TBL] [Abstract][Full Text] [Related]
33. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. Sipe JC; Arbour N; Gerber A; Beutler E J Leukoc Biol; 2005 Jul; 78(1):231-8. PubMed ID: 15845647 [TBL] [Abstract][Full Text] [Related]
34. A CARD9 single-nucleotide polymorphism rs4077515 is associated with reduced susceptibility to and severity of primary immune thrombocytopenia. Sheng Z; Li J; Wang Y; Li S; Hou M; Peng J; Feng Q Ann Hematol; 2019 Nov; 98(11):2497-2506. PubMed ID: 31595308 [TBL] [Abstract][Full Text] [Related]
36. "ITP" is not always immune thrombocytopenia. Holyome A; Cooper N; Qureshi A; Bain BJ Am J Hematol; 2020 Dec; 95(12):1614-1615. PubMed ID: 32419170 [No Abstract] [Full Text] [Related]
37. The relation between HLA-DRB1 alleles and the outcome of therapy in children with idiopathic thrombocytopenic purpura. El Neanaey WA; Barakat SS; Ahmed MA; El Nabie WM; Ahmed ME Egypt J Immunol; 2005; 12(2):29-38. PubMed ID: 17977208 [TBL] [Abstract][Full Text] [Related]
38. Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura. Kanhai D; Mulder R; Ploos van Amstel HK; Schutgens R; Lukens M; Tamminga RYJ Pediatr Blood Cancer; 2018 Dec; 65(12):e27418. PubMed ID: 30124235 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura during pregnancy. Vianelli N; Baravelli S; Milano V; Rizzo N; Catani L; Tura S Haematologica; 1998 Dec; 83(12):1127-8. PubMed ID: 9949634 [TBL] [Abstract][Full Text] [Related]
40. JAK2V617F mutation in immune thrombocytopenia. Huang CE; Chen YY; Liu JL; Ho HY; Li CP; Chen CC Thromb Res; 2016 Aug; 144():149-51. PubMed ID: 27344349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]